Coronavirus: China gives nothing away on whether it supports waiving vaccine IP protections

The debate over how to get enough supplies to vaccinate the world has pitted the Pope and the head of the World Health Organization against pharmaceutical executives, and seen developing countries resist the policies of wealthy nations.The issue is whether Covid-19 vaccine makers should lose intellectual property (IP) protections in a bid to ramp up global manufacturing and expand access to doses in poorer countries.The United States – a major vaccine producer that has so far kept most of its…

Read the original article at South China Morning Post